Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719497 · ClinicalTrials.gov registry record
Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 74
- Enrollment target
NCT01719497 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 74 participants.
The verdict
NCT01719497 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The aim of the present study is to conduct a human trial of \[C-11\]OMAR, a new PET imaging agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and binding characteristics.
Interventions
- DRUG [C-11]OMAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01719497
The ClinicalTrials.gov registry entry for NCT01719497 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [C-11]OMAR is the first listed.
NCT01719497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01719497 about?
NCT01719497 is a clinical study titled "Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET". The aim of the present study is to conduct a human trial of \[C-11\]OMAR, a new PET imaging agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and binding characteristics.
What is the current status of trial NCT01719497?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01719497?
The interventions under investigation include: [C-11]OMAR (DRUG).
Who is sponsoring clinical trial NCT01719497?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.